Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
about
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewContribution of amygdala pathology to comorbid emotional disturbances in temporal lobe epilepsy.EGAR, A Food Protein-Derived Tetrapeptide, Reduces Seizure Activity in Pentylenetetrazole-Induced Epilepsy Models Through α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptors.Disease modification in epilepsy: from animal models to clinical applications.Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy.Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle.A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsyThe role of substance P in epilepsy and seizure disorders.Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders.In Vivo Monitoring for Regional Changes of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Pilocarpine-Induced Epileptic Rat Brain by Small-Animal PET.Interactions Between Epilepsy and Plasticity.Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model.Single Session Low Frequency Left Dorsolateral Prefrontal Transcranial Magnetic Stimulation Changes Neurometabolite Relationships in Healthy Humans.The Role of Magnesium in Neurological Disorders.Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors
P2860
Q26743786-2E9F0436-B490-45E9-89FD-47ECB84AC2DCQ31015121-B4349DDF-AC0B-4CFE-93F7-98A07C5E0CFCQ36174777-A84D2FF0-CFEE-449D-9360-567E567CA0EDQ38450069-D6DFC155-A950-4CC8-84C9-1A5159B28042Q39016284-1815EFF6-4808-4FEE-8078-7E141F2DAADEQ39109344-2A26E200-51F5-40CD-B4D2-809DB59FFABBQ39291870-F343BE51-D413-4159-ACB7-AA2744AD1BDFQ41917625-F7ABB26D-0D50-41EA-9A70-8BC466086452Q44221614-225E15C9-0CA9-4D71-B426-DE50C06A621AQ44344083-31EAFEBE-809F-40F0-991D-2DF1644A2F02Q47120722-32467153-E95A-49E7-A320-6CC8E5384B4CQ50133892-E7031287-027F-429B-8E76-A4CE9AFE4025Q50417189-0753B82A-8065-4E86-90AB-2728F70C90C1Q52597690-35EE44B8-6584-47CA-9BD2-BCD8AF66B699Q55515107-75780058-A5CD-4DBB-A025-187A0C242EFFQ58694067-7EA2374F-D93C-42DD-BA59-4D2F096D2EA2
P2860
Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
@en
type
label
Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
@en
prefLabel
Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
@en
P2860
P1476
Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
@en
P2093
H Steve White
P2860
P304
P356
10.1101/CSHPERSPECT.A022863
P577
2015-06-22T00:00:00Z